Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-β/β-catenin pathway

Molecular Human Reproduction

Volumn 22, Issue 7, 2016, Pages 499-511

  Kang, Xiaomin ^a,b   Zhang, Xiaoxin ^a,b   Liu, Zhilan ^a,b   Xu, Haijing ^a,b   Wang, Tongfei ^a,b   He, Liying ^a,b   Zhao, Aimin ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Key Laboratory of Gynecologic Oncology   (China)

Author keywords

Feto maternal tolerance; Forkhead box P3; Myeloid derived suppressor cells; Transforming growth factor ; catenin

Indexed keywords

ARGINASE 1; B7 ANTIGEN; BETA CATENIN; CD115 ANTIGEN; CD135 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CHEMOKINE RECEPTOR CCR2; GLYCOPROTEIN P 15095; INDUCIBLE NITRIC OXIDE SYNTHASE; L SELECTIN; LYMPHOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; N BENZYL 1,2,3,4,8,9 HEXAHYDRO 6 (4 HYDROXYBENZYL) 8 (1 NAPHTHYLMETHYL) 4,7 DIOXO 2H PYRAZINO[1,2 A]PYRIMIDINE 1(6H) CARBOXAMIDE; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; CD4 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; INTERLEUKIN 2 RECEPTOR ALPHA;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BAGG ALBINO MOUSE; CBA MOUSE; CD4+ CD25+ T LYMPHOCYTE; CELL ISOLATION; CELL MATURATION; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; DBA 2 MOUSE; DECIDUA; EMBRYO; FEMALE; FETOPLACENTAL UNIT; FETUS; FETUS RESORPTION; FLOW CYTOMETRY; GRANULOCYTIC MYELOID DERIVED SUPPRESSOR CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PREGNANCY TERMINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SPONTANEOUS ABORTION; SUPPRESSOR CELL; WESTERN BLOTTING; ANIMAL; CELL CULTURE; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; METABOLISM; MYELOID-DERIVED SUPPRESSOR CELL; PHYSIOLOGY; T LYMPHOCYTE;

ADULT; ANIMALS; BETA CATENIN; CD4 ANTIGENS; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MICE; MICE, INBRED CBA; MYELOID-DERIVED SUPPRESSOR CELLS; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 84978734532     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gaw026     Document Type: Article

References (48)

1. Arck PC, Hecher K. Fetomaternal immune cross-talk and its consequences for maternal and offspring's health. Nat Med 2013;19:548-556.
2. Bansal AS. Joining the immunological dots in recurrent miscarriage. Am J Reprod Immunol 2010;64:307-315.
3. Brandau S, Trellakis S, Bruderek K, Schmaltz D, Steller G, Elian M, Suttmann H, Schenck M, Welling J, Zabel P et al. Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J Leukoc Biol 2011;89:311-317.
4. Bronte V, Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 2005;5:641-654.
5. Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell 2012; 149:1192-1205.
6. Cuss SM, Green EA. Abrogation of CD40-CD154 signaling impedes the homeostasis of thymic resident regulatory T cells by altering the levels of IL-2, but does not affect regulatory T cell development. J Immunol 2012; 189:1717-1725.
7. Delano MJ, Scumpia PO, Weinstein JS, Coco D, Nagaraj S, Kelly-Scumpia KM, O'Malley KA, Wynn JL, Antonenko S, Al-Quran SZ et al. MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med 2007;204:1463-1474.
8. Ding Y, Shen S, Lino AC, Curotto de Lafaille MA, Lafaille JJ. Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells. Nat Med 2008;14:162-169.
9. Erlebacher A. Mechanisms of T cell tolerance towards the allogeneic fetus. Nat Rev Immunol 2013;13:23-33.
10. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009;9:162-174.
11. Gabrilovich DI, Bronte V, Chen SH, Colombo MP, Ochoa A, Ostrand-Rosenberg S, Schreiber H. The terminology issue for myeloid-derived suppressor cells. Cancer Res 2007;67:425; author reply 6.
12. Garcia MR, Ledgerwood L, YangY,XuJ, Lal G, Burrell B,MaG, Hashimoto D, Li Y, Boros P et al. Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. J Clin Invest 2010;120:2486-2496.
13. GoniO, Alcaide P, FresnoM. Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G(Gr1(+))CD11b(+)immature myeloid suppressor cells. Int Immunol 2002;14:1125-1134.
14. Guerin LR, Prins JR, Robertson SA. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum Reprod Update 2009;15:517-535.
15. Huang B, Pan PY, Li Q, Sato AI, Levy DE, Bromberg J, Divino CM, Chen SH. Gr-1 + CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res 2006;66:1123-1131.
16. KostlinN, Kugel H, Spring B, Leiber A,MarmeA, Henes M, Rieber N, Hartl D, PoetsCF, Gille C. Granulocytic myeloid derived suppressor cells expand in human pregnancy and modulate T-cell responses. Eur J Immunol 2014; 44:2582-2591.
17. Kusmartsev S, Su Z, Heiser A, Dannull J, Eruslanov E, Kubler H, Yancey D, Dahm P, Vieweg J. Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma. Clin Cancer Res 2008; 14:8270-8278.
18. Li C,WangW,Wang H, Zhong Y, Di J, Lin Y. Proteomic analysis of proteins differentially expressed in uterine lymphocytes obtained from wild-type and NOD mice. J Cell Biochem 2009;108:447-457.
19. Li S, Vriend LE, Nasser IA, Popov Y, Afdhal NH, Koziel MJ, Schuppan D, Exley MA, Alatrakchi N. Hepatitis C virus-specific T cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesis. Hepatology 2012;56:2094-2105.
20. Liu CY, Wang YM, Wang CL, Feng PH, Ko HW, Liu YH, Wu YC, Chu Y, Chung FT, Kuo CH et al. Population alterations of L-arginase-and inducible nitric oxide synthase-expressed CD11b+/CD14(-)/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer. J Cancer Res Clin Oncol 2010;136:35-45.
21. Makarenkova VP, Bansal V, Matta BM, Perez LA, Ochoa JB. CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress. J Immunol 2006;176:2085-2094.
22. Marigo I, Dolcetti L, Serafini P, Zanovello P, Bronte V. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol Rev 2008;222:162-179.
23. Mauti LA, Le Bitoux MA, Baumer K, Stehle JC, Golshayan D, Provero P, Stamenkovic I. Myeloid-derived suppressor cells are implicated in regulating permissiveness for tumor metastasis during mouse gestation. J Clin Invest 2011;121:2794-2807.
24. Miller MM, Petty CS, Tompkins MB, Fogle JE. CD4 + CD25+ T regulatory cells activated during feline immunodeficiency virus infection convert T helper cells into functional suppressors through a membrane-bound TGFb/GARP-mediated mechanism. Virol J 2014;11:339-349.
25. Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C, Beschin A, De Baetselier P, Van Ginderachter JA. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008;111:4233-4244.
26. Nicholson LB, Raveney BJ, Munder M. Monocyte dependent regulation of autoimmune inflammation. Curr Mol Med 2009;9:23-29.
27. Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, Mandruzzato S, Bronte V. Myeloid-derived suppressor cell heterogeneity and subset definition. Curr Opin Immunol 2010;22:238-244.
28. Ribechini E, Greifenberg V, Sandwick S, Lutz MB. Subsets, expansion and activation of myeloid-derived suppressor cells. Med Microbiol Immunol 2010;199:273-281.
29. Sinha P, Clements VK, Ostrand-Rosenberg S. Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. J Immunol 2005;174:636-645.
30. Sinha P, Clements VK, Bunt SK, Albelda SM, Ostrand-Rosenberg S. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol 2007; 179:977-983.
31. Stromnes IM, Brockenbrough JS, Izeradjene K. Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity. Gut 2014;63:1769-1781.
32. Suzuki E, KapoorV, Jassar AS, Kaiser LR, Albelda SM. Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. Clin Cancer Res 2005;11:6713-6721.
33. Suzuki J, Ricordi C, Chen Z. Immune tolerance induction by integrating innate and adaptive immune regulators. Cell Transplant 2010;19:253-268.
34. Terness P, Kallikourdis M, Betz AG, Rabinovich GA, Saito S, Clark DA. Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells. Am J Reprod Immunol 2007;58:238-254.
35. Thaxton JE, Romero R, Sharma S. TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes. J Immunol 2009;183:1144-1154.
36. Tian J, ZhangY,Yang X, Rui K, Tang X,MaJ, Chen J,XuH, Lu L,Wang S. Ficus carica polysaccharides promote the maturation and function of dendritic cells. Int J Mol Sci 2014;15:12469-12479.
37. Tometten M, Blois S, Kuhlmei A, Stretz A, Klapp BF, Arck PC. Nerve growth factor translates stress response and subsequent murine abortion via adhesion molecule-dependent pathways. Biol Reprod 2006;74:674-683.
38. Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. Cell Biol 2003;162:899-908.
39. Van Ginderachter JA, Beschin A, De Baetselier P, Raes G. Myeloid-derived suppressor cells in parasitic infections. Eur J Immunol 2010;40:2976-2985.
40. Warning JC, McCracken SA, Morris JM. A balancing act: mechanisms by which the fetus avoids rejection by the maternal immune system. Reproduction 2011;141:715-724.
41. Westfall TA, Brimeyer R, Twedt J, Gladon J, Olberding A, Furutani-Seiki M, Slusarski DC. Wnt-5/pipetail functions in vertebrate axis formation as a negativeregulatorofWnt/beta-cateninactivity. J Cell Biol 2003;162:889-898.
42. Yin G, Li C, Shan B,WangW, Chen H, Zhong Y, Di J, Lin Q, Lin Y. Insufficient peroxiredoxin-2 expression in uterine NK cells obtained from a murine model of abortion. J Cell Biochem 2011;112:773-781.
43. Yin X, Wang X, Hu X, Chen Y, Zeng K, Zhang H. ERbeta induces the differentiation of cultured osteoblasts by both Wnt/beta-catenin signaling pathway and estrogen signaling pathways. Exp Cell Res 2015;335:107-114.
44. Youn JI, Gabrilovich DI. The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur J Immunol 2010;40:2969-2975.
45. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 2008;181:5791-5802.
46. Zhang L, Tu Y, HeW, Peng Y, Qiu Z. A novel mechanism of hepatocellular carcinoma cell apoptosis induced by lupeol via brain-derived neurotrophic factor inhibition and glycogen synthase kinase 3 beta reactivation. Eur J Pharmacol 2015;762:55-62.
47. Zhou Y, Yang X, Zhang H, Jiang J. The roles of T helper type 17/regulatory T cells in acute rejection after liver transplantation in rats. Transplantation 2015;99:1126-1131.
48. Zhu B, Bando Y, Xiao S, Yang K, Anderson AC, Kuchroo VK, Khoury SJ. CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J Immunol 2007;179:5228-5237.